期刊文献+
共找到907篇文章
< 1 2 46 >
每页显示 20 50 100
Reshaping the future of cancer therapy:taming toxicity and side effects 被引量:1
1
作者 Meng-Yao Li Heng Zhang +5 位作者 Jun Li Yi-Sheng Chen Shuai Ren Wen-Long Sun Qian Zhang Gokhan Zengin 《Biomedical Engineering Communications》 2026年第2期41-49,共9页
Cancer continues to pose a formidable challenge in global health,with conventional treatments such as chemotherapy and radiotherapy often resulting in severe toxicities that significantly degrade patients’quality of ... Cancer continues to pose a formidable challenge in global health,with conventional treatments such as chemotherapy and radiotherapy often resulting in severe toxicities that significantly degrade patients’quality of life and restrict therapeutic outcomes.Addressing this pressing issue,this review presents a thorough and systematic analysis of innovative and emerging strategies designed to minimize the toxicity induced by treatment,while maintaining or even enhancing antitumor efficacy.The focus is on six promising therapeutic approaches:combination therapies utilizing natural bioactive products,molecularly targeted therapies,immunotherapies,nanotechnology-mediated drug delivery systems,adjunct traditional Chinese medicine interventions,and low-dose spatiotemporally concerted regimens.Each approach employs unique mechanisms—such as enhanced targeting precision,immune system activation,tumor microenvironment reprogramming,and multi-component synergistic effects—to mitigate damage to normal tissues and reduce systemic adverse reactions.Despite promising preclinical and clinical advancements,several challenges persist,including drug resistance,high economic costs,a lack of reliable predictive biomarkers,and complexities in clinical translation and regulatory approval.Looking ahead,the incorporation of artificial intelligence,multi-omics profiling,and novel biomimetic nanotechnologies offers unprecedented opportunities for developing highly personalized,low-toxicity treatment frameworks.This review highlights a fundamental shift in oncology towards precision medicine that balances efficacy with safety,demonstrating the transformative potential of these strategies in shaping the future of cancer therapy and enhancing patient care globally. 展开更多
关键词 CANCER low toxicity combined therapies targeted therapies IMMUNOTHERAPIES nanotherapies traditional Chinese medicine spatiotemporally concerted therapies
暂未订购
Current understanding and prospects for targeting neurogenesis in the treatment of cognitive impairment
2
作者 Ye Liu Xibing Ding +1 位作者 Shushan Jia Xiyao Gu 《Neural Regeneration Research》 2026年第1期141-155,共15页
Adult hippocampal neurogenesis is linked to memory formation in the adult brain,with new neurons in the hippocampus exhibiting greater plasticity during their immature stages compared to mature neurons.Abnormal adult ... Adult hippocampal neurogenesis is linked to memory formation in the adult brain,with new neurons in the hippocampus exhibiting greater plasticity during their immature stages compared to mature neurons.Abnormal adult hippocampal neurogenesis is closely associated with cognitive impairment in central nervous system diseases.Targeting and regulating adult hippocampal neurogenesis have been shown to improve cognitive deficits.This review aims to expand the current understanding and prospects of targeting neurogenesis in the treatment of cognitive impairment.Recent research indicates the presence of abnormalities in AHN in several diseases associated with cognitive impairment,including cerebrovascular diseases,Alzheimer's disease,aging-related conditions,and issues related to anesthesia and surgery.The role of these abnormalities in the cognitive deficits caused by these diseases has been widely recognized,and targeting AHN is considered a promising approach for treating cognitive impairment.However,the underlying mechanisms of this role are not yet fully understood,and the effectiveness of targeting abnormal adult hippocampal neurogenesis for treatment remains limited,with a need for further development of treatment methods and detection techniques.By reviewing recent studies,we classify the potential mechanisms of adult hippocampal neurogenesis abnormalities into four categories:immunity,energy metabolism,aging,and pathological states.In immunity-related mechanisms,abnormalities in meningeal,brain,and peripheral immunity can disrupt normal adult hippocampal neurogenesis.Lipid metabolism and mitochondrial function disorders are significant energy metabolism factors that lead to abnormal adult hippocampal neurogenesis.During aging,the inflammatory state of the neurogenic niche and the expression of aging-related microRNAs contribute to reduced adult hippocampal neurogenesis and cognitive impairment in older adult patients.Pathological states of the body and emotional disorders may also result in abnormal adult hippocampal neurogenesis.Among the current strategies used to enhance this form of neurogenesis,physical therapies such as exercise,transcutaneous electrical nerve stimulation,and enriched environments have proven effective.Dietary interventions,including energy intake restriction and nutrient optimization,have shown efficacy in both basic research and clinical trials.However,drug treatments,such as antidepressants and stem cell therapy,are primarily reported in basic research,with limited clinical application.The relationship between abnormal adult hippocampal neurogenesis and cognitive impairment has garnered widespread attention,and targeting the former may be an important strategy for treating the latter.However,the mechanisms underlying abnormal adult hippocampal neurogenesis remain unclear,and treatments are lacking.This highlights the need for greater focus on translating research findings into clinical practice. 展开更多
关键词 aging Alzheimer's disease cerebrovascular diseases cognitive impairment energy metabolism HIPPOCAMPUS immune mechanisms NEUROGENESIS pathological states TREATMENT
暂未订购
Electric field stimulation-responsive hydrogels for bone regeneration:from mechanisms to applications
3
作者 Lizhi Ouyang Xi He +12 位作者 Yuheng Liao Xing Zhou Jiewen Liao Ze Lin Xudong Xie Weixian Hu Wenqian Zhang Fawwaz Al-Smadi Ranyang Tao Faqi Cao Yiqiang Hu Guohui Liu Bobin Mi 《Bone Research》 2026年第1期82-108,共27页
The continuous extension of human life expectancy and the global trend of population aging have contributed to a marked increase in the incidence of musculoskeletal diseases,with fractures and osteoporosis being promi... The continuous extension of human life expectancy and the global trend of population aging have contributed to a marked increase in the incidence of musculoskeletal diseases,with fractures and osteoporosis being prominent examples.Consequently,promoting bone regeneration is a crucial medical challenge that demands immediate attention.As early as the mid-20th century,researchers revealed that electrical stimulation could effectively promote the healing and regeneration of bone tissue.This is achieved by mimicking the endogenous electric field within bone tissue,which influences cellular behavior and molecular mechanisms.In recent years,electroactive hydrogels responsive to electric field stimulation have been developed and applied to regulate cell functions at different stages of bone regeneration.This paper elaborates on the regulatory effects of electrical stimulation on MSCs,macrophages,and vascular endothelial cells during the process of bone regeneration.It also involves the activation of relevant ion channels and signaling pathways.Subsequently,it comprehensively reviews various electric-field-responsive hydrogels developed in recent years,covering aspects such as material selection,preparation methods,characteristics,and their applications in bone regeneration.Ultimately,it provides an objective summary of the existing deficiencies in hydrogel materials and research,and looks ahead to future development directions. 展开更多
关键词 electrical stimulation mesenchymal stem cells MACROPHAGES HYDROGELS bone regeneration musculoskeletal diseaseswith population aging electric field stimulation
在线阅读 下载PDF
The mRNA-Based Innovative Strategy:Progress and Challenges
4
作者 Huayuan Zhou Dali Wei +8 位作者 Zhejie Chen Hao Chen Chuhuang Dong Wei Yao Jiawen Wang Xueliang Liu Yuqing Li Yu Yang Weihong Tan 《Nano-Micro Letters》 2026年第4期389-434,共46页
As the central template for protein expression,messenger ribonucleic acid(mRNA)holds immense potential for novel therapeutic strategies.Over the past few decades,mRNA-based therapeutics have demonstrated remarkable ef... As the central template for protein expression,messenger ribonucleic acid(mRNA)holds immense potential for novel therapeutic strategies.Over the past few decades,mRNA-based therapeutics have demonstrated remarkable efficacy in a range of applications,including epidemic vaccine,cancer vaccine,protein replacement therapy,cytokine therapy,cell therapy and gene editing.Due to the inherent instability of mRNA,the rational design of mRNA structure is the prerequisite for therapeutic utility while effective delivery systems are also essential for in vivo applications.This review focuses on the optimization of mRNA structure and highlights key delivery strategies.It also provides a comprehensive overview of the major applications of mRNA-based strategies.In addition,it highlights the persistent challenges in m RNA therapeutics,particularly in terms of stability,immunogenicity,delivery efficiency and safety.By examining recent advances in mRNA design,delivery and application,this review aims to support ongoing research and development in the field of mRNA-based therapeutics. 展开更多
关键词 mRNA structure optimization mRNA delivery system mRNA therapeutics
暂未订购
Circular RNAs:Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation
5
作者 Yimao Wu Yitong Liu +4 位作者 Ruowei Sun Yiyuan Zhang Qian Zhang Chen Li Mengyao Li 《Oncology Research》 2026年第3期1-37,共37页
Tumor metabolic reprogramming is a core hallmark of cancer,characterized by pathways such as aerobic glycolysis,aberrant lipid metabolism,and glutaminolysis that support rapid proliferation and immunosuppressive micro... Tumor metabolic reprogramming is a core hallmark of cancer,characterized by pathways such as aerobic glycolysis,aberrant lipid metabolism,and glutaminolysis that support rapid proliferation and immunosuppressive microenvironments.Circular RNAs(circRNAs)are highly stable,evolutionarily conserved non-coding RNAs that have emerged as critical modulators of these metabolic shifts.This review aims to systematically elucidate the roles and mechanisms of circRNAs in reprogramming tumor metabolism,and to discuss their clinical potential as biomarkers and therapeutic targets.Through mechanisms including miRNA sponging,protein interactions,regulation of mitochondrial dynamics,and modulation of metabolic enzymes,circRNAs influence key metabolic pathways by targeting glycolytic enzymes,lipid synthesis regulators,and glutaminolysis-related molecules to either facilitate or inhibit their expression.This review systematically summarizes the unique contributions of circRNAs to tumor metabolic reprogramming,highlighting key mechanisms such as regulation of peptide-encoding protein translation,mitochondrial localization function,gene promoter-targeted transcriptional regulation,and cross-pathway metabolic mediation,which underscore their distinct biological advantages and regulatory roles in tumor metabolism.The stability and tissue specificity of circRNAs make them promising diagnostic biomarkers,while their role in drug resistance mediated by metabolic reprogramming highlights their potential as therapeutic targets.Strategies such as circRNA inhibitors,mimics,and nanoparticle-based delivery systems are being explored to modulate tumor metabolism.Despite challenges including complex regulatory networks and limited manipulation tools,advances in high-throughput technologies and clinical trials hold promise for translating circRNA research into novel cancer therapies. 展开更多
关键词 Biomarkers circRNAs GLUTAMINOLYSIS lipid metabolism metabolic reprogramming therapeutic targets tumor metabolism
暂未订购
Mechanisms of exercise against anxiety disorder:A review of the research progress
6
作者 Zhengyuan Fang Yuan Qian +5 位作者 Shuya Sun Haochen Qin Yulian Zhu Jiayin Tang Shuo Chen Zhiwen Luo 《Sports Medicine and Health Science》 2026年第2期145-152,共8页
Objective: This review aims to explore the efficacy of exercise in the treatment of anxiety disorders and its underlying mechanisms, summarizing recent research advances and focusing on the potential biological and ps... Objective: This review aims to explore the efficacy of exercise in the treatment of anxiety disorders and its underlying mechanisms, summarizing recent research advances and focusing on the potential biological and psychological pathways through which exercise exerts its anxiolytic effects.Methods: To ensure comprehensive coverage of relevant studies, we conducted a systematic search in databases such as PubMed, Web of Science, and Embase, combining MeSH terms with free-text terms. Keywords included“exercise,” “physical activity,” and “anxiety disorder.”Results and conclusions: Current research widely supports exercise as a safe and effective intervention for anxiety.Both aerobic exercise and resistance training have shown significant anxiety-reducing effects across various populations. The mechanisms of action can be categorized into three main types: cellular and molecular mechanisms, systemic immune effects, and behavioral and cognitive pathways. Different forms of exercise have distinct advantages: aerobic exercise is suitable for the general population, resistance training is beneficial for individuals with coexisting physical conditions, and low-intensity exercises such as yoga and Tai Chi are suitable for pregnant women, the elderly, or postoperative recovery patients. Given its good safety profile and broad applicability, moderate exercise should be considered a first-line treatment for mild anxiety and an adjunctive intervention for moderate to severe anxiety. Future research should further clarify the mechanistic differences between various exercise modalities and promote the development of individualized exercise prescriptions. 展开更多
关键词 EXERCISE ANXIETY The medial prefrontal cortex NEUROPLASTICITY NEUROTRANSMITTER Immune system Interoceptive exposure
在线阅读 下载PDF
Single-Cell Sequencing Reveals Circadian Sensitivity of Noise-Induced Hearing Loss Mediated by Macrophage-Driven NLRP3 Inflammasome Activation
7
作者 Qingping Ma Qixuan Wang +9 位作者 Zixuan Zhu Qian Zhou Zhongying Wang Minfei Qian Teng Li Xixi Gu Zechuan Chen Xueling Wang Xiaoming Zhang Zhiwu Huang 《Neuroscience Bulletin》 2026年第2期319-337,共19页
Circadian sensitivity significantly influences the severity of noise-induced hearing loss(NIHL),but the underlying mechanisms remain unclear.Here,we applied single-cell RNA sequencing to 97,043 cochlear cells,identify... Circadian sensitivity significantly influences the severity of noise-induced hearing loss(NIHL),but the underlying mechanisms remain unclear.Here,we applied single-cell RNA sequencing to 97,043 cochlear cells,identifying macrophages as the primary immune responders to acoustic trauma,with a notable increase in their proportion in the cochlea.Immunofluorescence confirmed significant recruitment and activation of cochlear macrophages following noise exposure,while in vivo macrophage depletion resulted in the recovery of hearing.Furthermore,analyses of differentially-expressed genes and pathways revealed pronounced activation of NLRP3 inflammasome signaling in macrophages during night-time noise exposure.Measurements of elevated IL-1βand IL-18 expression in cochlear macrophages by multiplex immunohistochemistry correlated with heightened inflammation in the night-time exposure group.These findings were further confirmed by the administration of the selective NLRP3 inhibitor CY-09,which mitigated inflammasome activation,preserved synaptic integrity,and protect against hearing loss.In conclusion,our findings underscore the role of macrophage-driven NLRP3 inflammasome activation in mediating circadian variations in cochlear damage,offering a potential therapeutic target for mitigating NIHL. 展开更多
关键词 Noise-induced hearing loss MACROPHAGE NLRP3 inflammasome Circadian rhythm
原文传递
Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China 被引量:5
8
作者 Zi-Xuan Shen Dan-Dan Wu +36 位作者 Jie Xia Xian-Bo Wang Xin Zheng Yan Huang Bei-Ling Li Zhong-Ji Meng Yan-Hang Gao Zhi-Ping Qian Feng Liu Xiao-Bo Lu Jia Shang Hua-Dong Yan Yu-Bao Zheng Wen-Yi Gu Yan Zhang Jian-Yi Wei Wen-Ting Tan Yi-Xin Hou Qun Zhang Yan Xiong Cong-Cong Zou Jun Chen Ze-Bing Huang Xiu-Hua Jiang Sen Luo Yuan-Yuan Chen Na Gao Chun-Yan Liu Wei Yuan Xue Mei Jing Li Tao Li Xin-Yi Zhou Guo-Hong Deng Jin-Jun Chen Xiong Ma Hai Li 《World Journal of Gastroenterology》 SCIE CAS 2022年第31期4417-4430,共14页
BACKGROUND Autoimmune liver disease(AILD)has been considered a relatively uncommon disease in China,epidemiological data for AILD in patients with cirrhosis and acute decompensation(AD)is sparse.AIM To investigate the... BACKGROUND Autoimmune liver disease(AILD)has been considered a relatively uncommon disease in China,epidemiological data for AILD in patients with cirrhosis and acute decompensation(AD)is sparse.AIM To investigate the prevalence,outcome and risk factors for AILD in cirrhotic patients complicated with AD in China.METHODS We collected data from patients with cirrhosis and AD from two prospective,multicenter cohorts in hepatitis B virus endemic areas.Patients were regularly followed up at the end of 28-d,90-d and 365-d,or until death or liver transplantation(LT).The primary outcome in this study was 90-d LTfree mortality.Acute-on-chronic liver failure(ACLF)was assessed on admission and during 28-d hospitalization,according to the diagnostic criteria of the European Association for the Study of the Liver(EASL).Risk factors for death were analyzed with logistic regression model.RESULTS In patients with cirrhosis and AD,the overall prevalence of AILD was 9.3%(242/2597).Prevalence of ACLF was significantly lower in AILD cases(14%)than those with all etiology groups with cirrhosis and AD(22.8%)(P<0.001).Among 242 enrolled AILD patients,the prevalence rates of primary biliary cirrhosis(PBC),autoimmune hepatitis(AIH)and PBC-AIH overlap syndrome(PBC/AIH)were 50.8%,28.5%and 12.0%,respectively.In ACLF patients,the proportions of PBC,AIH and PBC/AIH were 41.2%,29.4% and 20.6%.28-d and 90-d mortality were 43.8% and 80.0% in AILD-related ACLF.The etiology of AILD had no significant impact on 28-d,90-d or 365-d LTfree mortality in patients with cirrhosis and AD in both univariate and multivariate analysis.Total bilirubin(TB),hepatic encephalopathy(HE)and blood urea nitrogen(BUN)were independent risk factors for 90-d LT-free mortality in multivariate analysis.The development of ACLF during hospitalization only independently correlated to TB and international normalized ratio.CONCLUSION AILD was not rare in hospitalized patients with cirrhosis and AD in China,among which PBC was the most common etiology.90-d LT-free mortality were independently associated with TB,HE and BUN. 展开更多
关键词 PREVALENCE Autoimmune liver disease Cirrhosis and acute decompensation MORTALITY Acuteon-chronic liver failure
暂未订购
Comprehensive evaluation method of epidemic prewarning and treatment for COVID-19 in general hospitals
9
作者 Wei LUAN Dong‑Ping ZHU +1 位作者 Wei‑Ren SHI Jin LI 《Journal of Integrative Nursing》 2020年第2期81-84,共4页
In recent years, due to frequent occurrence of public health emergencies, outbreaks of major infectious diseases represented by COVID-19have brought great harm to the lives and health of people. General hospitals are ... In recent years, due to frequent occurrence of public health emergencies, outbreaks of major infectious diseases represented by COVID-19have brought great harm to the lives and health of people. General hospitals are indispensable in disease prevention and control. The studyanalyzed a comprehensive evaluation method of epidemic prewarning and treatment for COVID‑19 in general hospitals through literature reviewand provided a reference for constructing urban public health prewarning and treatment system. 展开更多
关键词 COVID-19 evaluation index evaluation tool general hospital
暂未订购
Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer:Results from 24 hospitals in China 被引量:6
10
作者 Tai Ren Yong-Sheng Li +34 位作者 Xue-Yi Dang Yang Li Zi-Yu Shao Run-Fa Bao Yi-Jun Shu Xu-An Wang Wen-Guang Wu Xiang-Song Wu Mao-Lan Li Hong Cao Kun-Hua Wang Hong-Yu Cai Chong Jin Hui-Han Jin Bo Yang Xiao-Qing Jiang Jian-Feng Gu Yun-Fu Cui Zai-Yang Zhang Chun-Fu Zhu Bei Sun Chao-Liu Dai Lin-Hui Zheng Jing-Yu Cao Zhe-Wei Fei Chang-Jun Liu Bing Li Jun Liu Ye-Ben Qian Yi Wang Ya-Wei Hua Xi Zhang Chang Liu Wan-Yee Lau Ying-Bin Liu 《World Journal of Gastrointestinal Surgery》 SCIE 2021年第2期176-186,共11页
BACKGROUND Whether regional lymphadenectomy(RL)should be routinely performed in patients with T1b gallbladder cancer(GBC)remains a subject of debate.AIM To investigate whether RL can improve the prognosis of patients ... BACKGROUND Whether regional lymphadenectomy(RL)should be routinely performed in patients with T1b gallbladder cancer(GBC)remains a subject of debate.AIM To investigate whether RL can improve the prognosis of patients with T1b GBC.METHODS We studied a multicenter cohort of patients with T1b GBC who underwent surgery between 2008 and 2016 at 24 hospitals in 13 provinces in China.The logrank test and Cox proportional hazards model were used to compare the overall survival(OS)of patients who underwent cholecystectomy(Ch)+RL and those who underwent Ch only.To investigate whether combined hepatectomy(Hep)improved OS in T1b patients,we studied patients who underwent Ch+RL to compare the OS of patients who underwent combined Hep and patients who did not.RESULTS Of the 121 patients(aged 61.9±10.1 years),77(63.6%)underwent Ch+RL,and 44(36.4%)underwent Ch only.Seven(9.1%)patients in the Ch+RL group had lymph node metastasis.The 5-year OS rate was significantly higher in the Ch+RL group than in the Ch group(76.3%vs 56.8%,P=0.036).Multivariate analysis showed that Ch+RL was significantly associated with improved OS(hazard ratio:0.51;95%confidence interval:0.26-0.99).Among the 77 patients who underwent Ch+RL,no survival improvement was found in patients who underwent combined Hep(5-year OS rate:79.5%for combined Hep and 76.1%for no Hep;P=0.50).CONCLUSION T1b GBC patients who underwent Ch+RL had a better prognosis than those who underwent Ch.Hep+Ch showed no improvement in prognosis in T1b GBC patients.Although recommended by both the National Comprehensive Cancer Network and Chinese Medical Association guidelines,RL was only performed in 63.6%of T1b GBC patients.Routine Ch+RL should be advised in T1b GBC. 展开更多
关键词 Gallbladder cancer LYMPHADENECTOMY HEPATECTOMY STAGING PROGNOSIS SURGERY
暂未订购
Challenges for pediatric liver transplantation in the mainland of China:Where we are and where to go.Reflections from worldwide largest pediatric liver transplantation program 被引量:4
11
作者 Qiang Xia Ming-Xuan Feng 《Hepatobiliary & Pancreatic Diseases International》 2025年第1期35-38,共4页
In China pediatric liver transplantation(PLT)has become a safe and standardized procedure.Innovations and measures to further improve long-term survival and quality of life for children should be the next focus.In par... In China pediatric liver transplantation(PLT)has become a safe and standardized procedure.Innovations and measures to further improve long-term survival and quality of life for children should be the next focus.In particular better strategies related to the surgical treatment of high-risk recipients as well as the long-term follow-up of pediatric liver recipients have to be addressed.A particular attention should be given to children presenting significant co-morbidities and those needing retransplantation.A tight mul-tidisciplinary follow-up system addressing both short-and long-term issues of pediatric liver recipients is still a challenge for the Chinese pediatric transplant community. 展开更多
关键词 Pediatric liver transplantation RETRANSPLANTATION COMORBIDITY
暂未订购
An incidental but life-threatening bowel obstructiongallstone ileus:a case report 被引量:1
12
作者 Meng Sha Xiaoye Qu +2 位作者 Wenqing Lu Jie Cao Qiang Xia 《World Journal of Emergency Medicine》 2025年第6期617-619,共3页
Gallstone ileus is an uncommon but life-threatening form of mechanical small bowel obstruction,[1]especially in elderly female patients.[2]It is caused by large gallstone impaction that enters the bowel via a cholecys... Gallstone ileus is an uncommon but life-threatening form of mechanical small bowel obstruction,[1]especially in elderly female patients.[2]It is caused by large gallstone impaction that enters the bowel via a cholecystoduodenal fistula.Since the rarity of gallstone ileus is associated with relatively high rates of morbidity and mortality in elderly patients with multiple comorbidities,making an early and accurate diagnosis in emergency settings crucial. 展开更多
关键词 mechanical small bowel obstruction especially elderly patients large gallstone impaction emergency settings mechanical small bowel obstruction cholecystoduodenal fistulasince gallstone ileus cholecystoduodenal fistula
暂未订购
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway 被引量:2
13
作者 Min Chen Jin-Bo Zhao +12 位作者 Guang-Bo Wu Zheng-Hao Wu Gu-Qing Luo Zhi-Feng Zhao Chi-Hao Zhang Jia-Yun Lin Hong-Jie Li Xiao-Liang Qi Hai-Zhong Huo Abudukadier Tuersun Qiang Fan Lei Zheng Meng Luo 《World Journal of Gastroenterology》 2025年第10期86-102,共17页
BACKGROUND Liver cirrhosis and portal hypertension(PHT)can lead to lymphatic abnormalities and coagulation dysfunction.Because lymphangiogenesis may relieve liver cirrhosis and PHT,the present study investigated the g... BACKGROUND Liver cirrhosis and portal hypertension(PHT)can lead to lymphatic abnormalities and coagulation dysfunction.Because lymphangiogenesis may relieve liver cirrhosis and PHT,the present study investigated the gene expression alterations in the lymphatic system and the effectiveness of platelet-mediated lymphangiogenesis in improving liver cirrhosis and PHT.AIM To investigate the role of lymphangiogenesis in preclinical PHT models.METHODS Immunohistochemistry and transcriptome sequencing of bile duct ligation(BDL)and control lymphatic samples were conducted to reveal the indicated signaling pathways.Functional enrichment analyses were performed on the differentially expressed genes and hub genes.Adenoviral infection of vascular endothelial growth factor C(VEGF-C),plateletrich plasma(PRP),and VEGF3 receptor(VEGFR)inhibitor MAZ-51 was used as an intervention for the lymphatic system in PHT models.Histology,hemodynamic tests and western blot analyses were performed to demonstrate the effects of lymphatic intervention in PHT patients.RESULTS Lymphangiogenesis was increased in the BDL rat model.Transcriptome sequencing analysis of the extrahepatic lymphatic system revealed its close association with platelet adherence,aggregation,and activation.The role of PHT in the rat model was investigated by activating(PRP)and inhibiting(MAZ-51)the lymphatic system.PRP promoted lymphangiogenesis,which increased lymphatic drainage,alleviated portal pressure,reduced liver fibrosis,inhibited inflammation,inhibited angiogenesis,and suppressed mesenteric artery remodeling.MAZ-51 reversed the above improvements.CONCLUSION Via VEGF-C/VEGFR-3,platelets impede fibrosis,angiogenesis,and mesenteric artery remodeling,ultimately alleviating PHT.Thus,platelet intervention is a therapeutic approach for cirrhosis and PHT. 展开更多
关键词 Portal hypertension CIRRHOSIS LYMPHANGIOGENESIS PLATELETS Vascular endothelial growth factor C
暂未订购
Inflammatory macrophage-derived itaconate inhibits DNA demethylase TET2 to prevent excessive osteoclast activation in rheumatoid arthritis 被引量:2
14
作者 Kewei Rong Dezheng Wang +12 位作者 Xiting Pu Cheng Zhang Pu Zhang Xiankun Cao Jinglin Zheng Xiao Yang Kexin Liu Lei ShiYin Li Peixiang Ma Dan Ye Jie Zhao Pu Wang An Qin 《Bone Research》 2025年第5期1188-1200,共13页
Itaconate,a macrophage-specific anti-inflammatory metabolite,has recently emerged as a critical regulator in rheumatoid arthritis pathogenesis.We found that itaconate is a TNF-αresponsive metabolite significantly ele... Itaconate,a macrophage-specific anti-inflammatory metabolite,has recently emerged as a critical regulator in rheumatoid arthritis pathogenesis.We found that itaconate is a TNF-αresponsive metabolite significantly elevated in the serum and synovial fluid of rheumatoid arthritis patients and we demonstrated that itaconate is primarily produced by inflammatory macrophages rather than osteoclasts or osteoblasts.In TNF-transgenic and Irg1−/−hybrid mice,a more severe bone destruction phenotype was observed. 展开更多
关键词 osteoclast activation bone destruction phenotype itaconate TET synovial fluid rheumatoid arthritis patients inflammatory macrophages rheumatoid arthritis
暂未订购
Association between autoimmune gastritis and gastric polyps:Clinical characteristics and risk factors
15
作者 Jing-Zheng Jin Xiao Liang +4 位作者 Shu-Peng Liu Rui-Lan Wang Qing-Wei Zhang Yu-Feng Shen Xiao-Bo Li 《World Journal of Gastrointestinal Oncology》 SCIE 2025年第1期73-87,共15页
BACKGROUND The relationship between autoimmune gastritis(AIG)and gastric polyps(GPs)is not well understood.AIM To explore the clinical characteristics and risk factors of AIG with GPs in patients.METHODS This double c... BACKGROUND The relationship between autoimmune gastritis(AIG)and gastric polyps(GPs)is not well understood.AIM To explore the clinical characteristics and risk factors of AIG with GPs in patients.METHODS This double center retrospective study included 530 patients diagnosed with AIG from July 2019 to July 2023.We collected clinical,biochemical,serological,and demographic data were of each patient.Logistic regression analyses,both multivariate and univariate,were conducted to pinpoint independent risk factors for GPs in patients with AIG patients.Receiver operating characteristic curves were utilized to establish the optimal cutoff values,sensitivity,and specificity of these risk factors for predicting GPs in patients with AIG.RESULTS Patients with GPs had a higher median age than those without GPs[61(52.25-69)years vs 58(47-66)years,P=0.006].The gastrin-17 levels were significantly elevated in patients with GPs compared with those without GPs[91.9(34.2-138.9)pmol/mL vs 60.9(12.6-98.4)pmol/mL,P<0.001].Additionally,the positive rate of parietal cell antibody(PCA)antibody was higher in these patients than in those without GPs(88.6%vs 73.6%,P<0.001).Multivariate and univariate analyses revealed that PCA positivity[odds ratio(OR)=2.003,P=0.017],pepsinogen II(OR=1.053,P=0.015),and enterochromaffin like cells hyperplasia(OR=3.116,P<0.001)were significant risk factors for GPs,while pepsinogen I was identified as a protective factor.CONCLUSION PCA positivity and enterochromaffin like cells hyperplasia are significant risk factor for the development of GPs in patients with AIG.Elevated gastrin-17 levels may also play a role in this process.These findings suggest potential targets for further research and therapeutic intervention in managing GPs in patients with AIG. 展开更多
关键词 Autoimmune gastritis Gastric polyps Neuroendocrine tumor Risk factors NOMOGRAM
暂未订购
The China Alzheimer Report 2025 被引量:7
16
作者 Nan Zhi Rujing Ren +35 位作者 Jinlei Qi Xinya Liu Zike Yun Shaohui Lin Yisong Hu Haixia Li Xinyi Xie Jintao Wang Jianping Li Yikang Zhu Mengyi Gao Junjie Yang Yiran Wang Yurong Jing Jieli Geng Wenwei Cao Qun Xu Xiaoping Yu Yuan Zhu Ying Zhou Lin Wang Chao Gao Binyin Li Shengdi Chen Fang Yuan Ronghua Dou Xiaoyun Liu Xuena Li Yafu Yin Yan Chang Gang Xu Yanting Zhong Chunbo Li Ying Wang Maigeng Zhou Gang Wang 《General Psychiatry》 2025年第4期245-259,共15页
With the sustained growth of the economy and significant changes in social demographics,the issue of elderly-related diseases has increasingly drawn attention,particularly.Alzheimer’s disease(AD),as a representative ... With the sustained growth of the economy and significant changes in social demographics,the issue of elderly-related diseases has increasingly drawn attention,particularly.Alzheimer’s disease(AD),as a representative disease of neurodegenerative diseases,has become a major challenge,affecting the health and quality of life of the elderly population severely.In recent years,the incidence,prevalence and mortality rates of AD have increased in China,imposing substantial economic burdens on families,society and the entire healthcare system.To proactively address this challenge and respond to the national‘Healthy China Action’initiative,leading experts from authoritative institutions jointly authored the China Alzheimer Report 2025.Building on previous editions,this report updates epidemiological data on AD in China,thoroughly analyses the latest economic burdens of the disease and comprehensively evaluates the current status of AD diagnosis and treatment services,as well as the allocation of public health resources in our country.Its release reflects China’s progress in AD research and prevention,underscores societal concern for elderly health and aims to provide scientific guidance and data support for AD prevention,diagnosis and treatment.It also facilitates academic exchanges and cooperation,enhancing public awareness and promoting active participation in elderly healthcare,towards achieving‘healthy ageing’in China. 展开更多
关键词 elderly health healthy aging diagnosis treatment economic burden China societal concern Alzheimers disease public health resources
暂未订购
Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies:ASAP score versus GALAD score 被引量:2
17
作者 Li-Yang Sun Nan-Ya Wang +11 位作者 Yong-Kang Diao Cun-Lin Yan Zhu-Ping Fan Lian-Hua Wei Hui-Jun Li Ming-Cheng Guan Ming-Da Wang Timothy M Pawlik Wan Yee Lau Feng Shen Guo-Yue Lv Tian Yang 《Hepatobiliary & Pancreatic Diseases International》 2025年第4期412-422,共11页
Background:Diagnostic panels based on multiple biomarkers and clinical characteristics are considered more favorable than individual biomarker to diagnose hepatocellular carcinoma(HCC).Based on age,sex,alpha-fetoprote... Background:Diagnostic panels based on multiple biomarkers and clinical characteristics are considered more favorable than individual biomarker to diagnose hepatocellular carcinoma(HCC).Based on age,sex,alpha-fetoprotein(AFP),and protein induced by vitamin K absence II(PIVKA-II)with/without AFP-L3,ASAP and GALAD models are potential diagnostic panels.The diagnostic performances of these two panels were compared relative to HCC detection among patients with various etiologies of chronic liver diseases(CLDs).Methods:A multicenter case-control study recruited CLDs patients with and without HCC from 14 Chi-nese hospitals.The etiologies of CLDs included hepatitis B virus(HBV),hepatitis C virus(HCV),alcoholic liver disease(ALD),and nonalcoholic fatty liver disease(NAFLD).Using area under the receiver operating characteristic curve(AUC)values,the diagnostic performances of ASAP and GALAD models were com-pared to detect HCC among patients with various etiologies of CLDs.Results:Among 248 HCC patients and 722 CLD controls,the ASAP model demonstrated the highest AUC(0.886)to detect HCC at any stage,outperforming the GALAD model(0.853,P=0.001),as well as any individual biomarker(0.687-0.799,all P<0.001).In the subgroup analysis of various CLDs etiologies,the ASAP model outperformed the GALAD model to HCC independent of CLDs etiology.In addition,the ASAP model performed better in detecting early-stage(BCLC stage 0/A)HCC versus the GALAD model.Conclusions:Despite using one less laboratory variable(AFP-L3),the ASAP model demonstrated better diagnostic performance than the GALAD model to detect all-stage HCC among patients with various eti-ologies of CLDs-related HCC. 展开更多
关键词 Hepatocellular carcinoma Biomarker panel ASAP GALAD Diagnosis
暂未订购
Esophageal fistula after resection of giant mediastinal liposarcoma:A case report
18
作者 Yi-Zong Ding Dao-Qiang Tang Xiao-Jing Zhao 《World Journal of Clinical Cases》 2025年第35期52-58,共7页
BACKGROUND Liposarcoma is the most common soft tissue tumor in adults.Liposarcoma commonly occurs in the lower extremities and retroperitoneum but rarely in the mediastinum.To the best of our knowledge,this is the fir... BACKGROUND Liposarcoma is the most common soft tissue tumor in adults.Liposarcoma commonly occurs in the lower extremities and retroperitoneum but rarely in the mediastinum.To the best of our knowledge,this is the first report of bilateral single-port video-assisted thoracoscopic surgery(VATS)for giant mediastinal liposarcoma and the first report of esophageal fistula after this surgery.CASE SUMMARY We present the case of a 71-year-old male patient with a giant posterior mediastinal tumor.Chest computed tomography and magnetic resonance imaging showed that the tumor completely involved the esophagus.The patient underwent bilateral single-port VATS and the tumor was completely removed.An esophageal fistula was detected 9 days after surgery and 2 days after eating.Emergency debridement surgery was performed,and a drainage tube was placed.The fistula healed gradually after the second surgery.CONCLUSION VATS is safer than thoracotomy for treating giant mediastinal liposarcoma.For tumors extensively involving the esophagus,preventive measures against esophageal fistula are necessary. 展开更多
关键词 LIPOSARCOMA MEDIASTINUM Bilateral single-port video-assisted thoracoscopic surgery surgery Esophageal fistula Case report
暂未订购
Internal biliary diversion using appendix during liver transplantation for progressive familial intrahepatic cholestasis type 1:A case report
19
作者 Jia-Qi Song Tao Zhou +1 位作者 Yi Luo Yuan Liu 《World Journal of Gastrointestinal Surgery》 2025年第2期279-284,共6页
BACKGROUND Progressive familial intrahepatic cholestasis type 1(PFIC-1)is a genetic cholestatic disease causing end-stage liver disease,which needs liver transplantation(LT).Simultaneous biliary diversion(BD)was recom... BACKGROUND Progressive familial intrahepatic cholestasis type 1(PFIC-1)is a genetic cholestatic disease causing end-stage liver disease,which needs liver transplantation(LT).Simultaneous biliary diversion(BD)was recommended to prevent allograft steatosis after transplantation,while increasing the risk of infection.Here,an attempt was made to perform BD using appendix to prevent bacterial translocation after LT.CASE SUMMARY An 11-month-old boy diagnosed with PFIC-1 received ABO compatible living donor LT due to refractory jaundice and pruritus.His mother donated her left lateral segment with a graft-to-recipient weight ratio of 2.9%.Internal BD was constructed during LT using the appendix by connecting its proximal end with the intrahepatic biliary duct and the distal end with colon.Biliary leakage was suspected on the 5th day after transplantation and exploratory laparotomy indicated biliary leakage at the cutting surface of liver.The liver function returned to normal on the 9th day post-operation and maintained normal during the 15-month follow-up.Cholangiography at 10 months after transplantation confirmed the direct secretion of bile into colon.Computerized tomography scan(4 months and 10 months)and liver biopsy(10 months)indicated no steatosis in the allograft.No complaint of recurrent diarrhea,infection or growth retardation was reported during follow-up.CONCLUSION Internal BD using appendix during LT is effective in preventing allograft steatosis and post-transplant infection in PFIC-1 recipients. 展开更多
关键词 Liver transplantation Progressive familial intrahepatic cholestasis type 1 Biliary diversion APPENDIX Case report
暂未订购
Lymphatic-venous anastomosis surgery for Alzheimer’s disease
20
作者 Hualong Wang Allan Levey Gang Wang 《General Psychiatry》 2025年第3期242-244,共3页
Lymphatic-venous anastomosis(LVA)surgery has recently emerged as a potential treatment for Alzheimer’s disease(AD)in China.This minimally invasive microsurgical procedure has been used for decades to treat lymphoedem... Lymphatic-venous anastomosis(LVA)surgery has recently emerged as a potential treatment for Alzheimer’s disease(AD)in China.This minimally invasive microsurgical procedure has been used for decades to treat lymphoedema,typically in the limbs,to decompress blocked lymphatic drainage pathways. 展开更多
关键词 lymphatic venous anastomosis SURGERY decompress blocked lymphatic drainage pathways alzheimer s disease microsurgical procedure minimally invasive microsurgical procedure LYMPHOEDEMA treat lymphoedematypically
暂未订购
上一页 1 2 46 下一页 到第
使用帮助 返回顶部